Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato
Conflicting evidence-based guidelines and medication risks have complicated the care of individuals with low bone density. The Endocrine Society just released its most recent recommendations for pharmacologic management of postmenopausal women with osteoporosis. Their goal was to address the most challenging aspects of low bone density management with clear evidence-based guidance. Join us as we review their new recommendations, compare them with other guidelines, and discuss their impact on your practice.